Literature DB >> 12325497

[Polymyalgia rheumatica revisited].

Pablo Przygoda1, Luis J Catoggio, Enrique R Soriano, Patricia M Imamura, Luis A Camera, Roberto Kaplan, Luis M Mayorga.   

Abstract

Polymyalgia rheumatica is an inflammatory disorder that usually affects persons over the age of 50 causing proximal muscle pain and stiffness, and an elevated erythrocyte sedimentation rate. Although increasingly recognized in this age group, it remains a diagnosis of exclusion and although several diagnostic criteria have been proposed, none has been clearly accepted. While polymyalgia rheumatica is associated with giant cell arteritis, obtaining a temporal artery biopsy is not recommended in patients with polymyalgia rheumatica without symptoms of giant cell arteritis. Early diagnosis and low dose corticosteroid therapy improve patients' clinical features and functional status. Treatment usually lasts between 12 and 24 months and the majority of patients manage to discontinue treatment completely.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12325497

Source DB:  PubMed          Journal:  Medicina (B Aires)        ISSN: 0025-7680            Impact factor:   0.653


  2 in total

1.  [Descriptive study of a polymyalgia rheumatica case series in a Primary Care Centre].

Authors:  Anna Palomeras Vilches; Anna Picas Jufresa; José Cristóbal Buñuel Alvarez; Clauce Gassen
Journal:  Aten Primaria       Date:  2009-05-20       Impact factor: 1.137

2.  Prevalence of polymyalgia rheumatica in Colombia: data from the national health registry 2012-2016.

Authors:  Daniel G Fernández-Ávila; Santiago Bernal-Macías; Diana N Rincón-Riaño; Juan M Gutiérrez; Diego Rosselli
Journal:  Rheumatol Int       Date:  2019-07-20       Impact factor: 2.631

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.